Why is Dr Reddy's Labs falling/rising?

As of 22-Jul, Dr Reddys Laboratories Ltd is experiencing a decline in its stock price, currently at 1,240.40, which reflects a decrease of 19.1 points or 1.52%. The stock has underperformed its sector by 0.61% today, and while it is above the 100-day moving average, it remains below the 5-day, 20-day, 50-day, and 200-day moving averages. Over the past week, the stock has decreased by 1.54%, and it has shown a significant decline of 10.65% year-to-date, contrasting with a positive return of 5.18% for the benchmark index, Sensex. Despite these declines, the company has a low debt-to-equity ratio and strong long-term fundamentals, including a healthy growth rate in net sales and operating profit, which may provide some support for the stock.
Broader market context indicates that Dr Reddys Laboratories Ltd has underperformed relative to the Sensex in the short term, with a 1-week return of -1.54% compared to the benchmark's -0.47%. The stock's performance over the past year has also been negative at -7.73%, while the Sensex has gained 2.09%. Additionally, the company has high institutional holdings at 62.91%, which could indicate confidence among larger investors despite the recent price decline. However, the flat results reported in March and a decrease in profit before tax suggest underlying challenges that may be contributing to the stock's downward movement.